Medical Devices

New preclinical data reveals a novel gene therapy that not only kills tumor cells but also boosts immunity, offering hope against drug-resistant lung cancer.

Student innovators unveil an AI lifeline for ICUs at Quest Global's Ingenium, tackling a critical medical crisis and showcasing India's engineering future.

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.

The deal, part of a broader consolidation strategy by parent The Lockwood Group, aims to meet rising pharma demand for advanced data and patient services.

With late-breaking hypertension data and an AI-driven platform, Kardigan is set to showcase a new, personalized approach to cardiovascular medicine.

A new strategic partnership aims to unite California's life science hubs, creating a streamlined path to capital for medtech and biotech startups.

The FDA grants PolyPid a crucial $4.3 million fee waiver for its D-PLEX₁₀₀ drug, freeing up vital cash to accelerate its commercial launch.

A century-old cardiology group is expanding advanced heart care in the Mid-South by partnering with Atria Health, challenging the trend of hospital buyouts.

Belgian firm Endo Tools Therapeutics wins US approval for its next-gen endomina® EZFuse, a device promising to cut GI procedure times by up to 50%.

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

A new telehealth model challenges the prescription-first approach, combining GLP-1s with 24/7 clinical support. Is this the future of metabolic health?

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

A new exoskeleton, validated by scientific studies, shows a dramatic reduction in muscle strain and discomfort for surgeons, dentists, and industrial workers.

Regulatory pressure ends a major ophthalmic deal, forcing LENSAR to forge ahead alone with its ALLY system and a $10M deposit. What's next?

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Riding a wave of record revenue and a new product launch, iRadimed showcases its MRI-compatible device dominance to investors, aiming to fuel future growth.

As essential pediatric care costs skyrocket, families of children with cerebral palsy face a silent crisis of debt, stress, and impossible choices.

The global manufacturer's latest acquisition adds key blow molding capabilities and expands its U.S. footprint, signaling a major push into the medical sector.